Skip to main content
. 2020 Nov 26;27(2 Suppl):27–34. doi: 10.1177/2047487320960288

Figure 3.

Figure 3.

Kaplan–Meier analysis of study endpoint (composite of cardiovascular (CV) death, urgent heart transplant (HTX) or left ventricular assist device (LVAD) implantation) according to β-blocker equivalent dose at a 10-year follow-up (p < 0.0001). Blue line = no β-blocker, red line = low dose (≤12.5 mg/day), yellow line = medium dose (>12.5–≤25 mg/day), green line = high dose (25 mg/day). Modified from Campodonico et al.42